TRVI Trevi Therapeutics, Inc.
$14.50
▲ 3.20%
43
Value
28
P/E-46.28
8
P/B12.26
40
P/S0.00
70
EV/EBITDA-43.15
5
Growth
38
Revenue Growth0.0%
28
EPS Growth38.3%
46
FCF Growth-10.0%
43
Momentum
82
12-Month Return117.7%
100
3-Month Return26.5%
100
1-Month Return9.0%
70
RSI (14)39.77
50
50/200 MABullish
75
ROE-24.5%
47
ROA-25.4%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-1.6%
2
Risk
41
Beta1.08
90
60-Day Volatility55.6%
0
Get an email when the QScore signal flips. No daily noise.
QScore Analysis